MIKHAIL LEZHAK: Open Payments
NPI 1184807166 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,254 in 34 payments from 17 companies in 2025. Trend: 2023 $609 · 2024 $525 · 2025 $1,254
Food & beverage: $1,091Education: $163
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 5 | $288 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $185 |
| SEAGEN INC. | 1 | $85 |
| Astellas Pharma US Inc | 1 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Ferring Pharmaceuticals Inc. | 1 | $71 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| ABBVIE INC. | 3 | $57 |
| Telix Pharmaceuticals | 1 | $54 |
| Medtronic, Inc. | 1 | $50 |
Products named: PROVENGE, Nubeqa, PLUVICTO, ADSTILADRIN, ILLUCCIX, KEYTRUDA, INTERSTIM, XTANDI.
Industry payments across FL — which companies pay providers there.
